查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750699

非小细胞肺癌治疗市场规模、份额、趋势分析报告：按类型、治疗方法、分销管道、地区和细分市场预测，2025 年至 2030 年

Non-small Cell Lung Cancer Therapeutics Market Size, Share & Trends Analysis Report By Type, By Treatment, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

非小细胞肺癌治疗市场的成长与趋势

根据Grand View Research, Inc.的最新报告，全球非小细胞肺癌治疗市场规模预计到2030年将达到438.9亿美元，2025年至2030年期间的复合年增长率为12.71%。

预计非小细胞肺癌 (NSCLC) 市场将在预测期内显着增长，这得益于市场参与企业在肺癌治疗研发方面的大量投资、丰富的产品线以及预测期内药物渗透率的提高。

预计在预测期内，多种药物在不同地区的上市将推动市场发展。例如，2016年10月，美国食品药物管理局（FDA）授予基因泰克公司（Genentech）开发的用于治疗ALK阳性非小细胞肺癌（NSCLC）的第一线药物Alecensa（Alectinib）突破性疗法认定。该药物已在美国、日本、加拿大、香港、韩国、科威特和以色列核准。

预测期内，强大的非小细胞肺癌治疗产品线将推动市场发展。百时美施贵宝公司、Orion Corporation、默克公司、阿斯特捷利康、罗氏公司和辉瑞公司均已在其产品线中拥有关键分子药物。

非小细胞肺癌治疗市场报告重点

  • 由于消费烟草和其他吸烟产品的人口不断增加，腺癌部分占据了市场的主导地位，到 2024 年将占据 43.39% 的份额。预计鳞状细胞癌 (SCC) 部分在预测期内的复合年增长率最快。
  • 标靶治疗领域占据主导地位，2024 年的市占率为 50.66%。预计免疫治疗领域在预测期内将以显着的复合年增长率成长。
  • 医院药房部门占据市场主导地位，2024 年的份额为 66.89%。由于可供寻求治疗 NSCLC 的患者使用的经监管部门核准的药物越来越多，预计药局和零售药局部门在预测期内将呈现显着的复合年增长率。
  • 北美非小细胞肺癌 (NSCLC) 治疗产业占据全球市场占有率为 35.41%。亚太地区非小细胞肺癌 (NSCLC) 治疗行业正在经历快速增长，这得益于肺癌发病率上升、政府对肿瘤医疗保健的投资以及区域伙伴关係的不断加强，以获得更广泛的生技药品和标靶药物。

目录

第一章调查方法与范围

第二章执行摘要

3. 非小细胞肺癌治疗市场变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 非小细胞肺癌治疗市场分析工具
    • 波特分析
    • PESTEL分析
  • 管道分析
  • 定价分析

第四章 非小细胞肺癌治疗市场：按类型估计和趋势分析

  • 细分仪表板
  • 非小细胞肺癌治疗市场占有率（按类型划分）（2024 年和 2030 年，百万美元）
  • 鳞状细胞癌
  • 大细胞癌
  • 腺癌
  • 其他的

第五章非小细胞肺癌治疗市场：治疗方法的估计和趋势分析

  • 细分仪表板
  • 非小细胞肺癌治疗市场占有率（按治疗方法）（2024 年和 2030 年，百万美元）
  • 化疗
  • 标靶治疗
  • 免疫疗法
  • 其他的

第六章非小细胞肺癌治疗市场：按分销管道的估计和趋势分析

  • 细分仪表板
  • 非小细胞肺癌治疗市场占有率（2024 年和 2030 年，百万美元）
  • 医院药房
  • 药局和零售药局
  • 网路药局

第七章非小细胞肺癌治疗市场：按地区估计和趋势分析

  • 非小细胞肺癌治疗市场占有率（2024 年和 2030 年，百万美元）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
    • F. Hoffmann-La Roche Ltd
    • Mylan NV
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Pfizer Inc.
    • GSK plc
    • Novartis AG
    • Bayer AG
    • Eli Lilly and Company
    • Merck & Co., Inc
Product Code: GVR-1-68038-703-2

Non-small Cell Lung Cancer Therapeutics Market Growth & Trends:

The global non-small cell lung cancer therapeutics market size is expected to reach USD 43.89 billion by 2030, registering a CAGR of 12.71% from 2025 to 2030, according to a new report by Grand View Research, Inc. The non-small cell cancer therapeutics (NSCLC) market is anticipated to witness significant growth during the forecast period. This can be attributed to the high investment by market players in the research and development of lung cancer therapy, presence of a rich pipeline, and increasing penetration of drugs during the forecast period.

Introduction of several drugs in various geographical regions is likely to drive the market during the forecast period. For instance, in October 2016, the FDA granted Breakthrough Therapy Designation to Alecensa (alectinib), a drug developed by Genentech to treat ALK-positive NSCLC as a first-line treatment. The drug has been approved in the U.S., Japan, Canada, Hong Kong, South Korea, Kuwait, and Israel.

Presence of a strong pipeline of drugs for non-small cell lung cancer helps propel the market during the forecast period. Bristol-Myers Squibb Company, Orion Corporation, Merck KGaA, AstraZeneca, F. Hoffmann-La Roche Ltd, and Pfizer, Inc. have major molecules in the pipeline.

Non-small Cell Lung Cancer Therapeutics Market Report Highlights:

  • The adenocarcinoma segment dominated the market in 2024 with a share of 43.39% in 2024 due to an increase in the population consuming tobacco and other products for smoking. The squamous cell carcinoma (SCC) segment is anticipated to witness the fastest CAGR over the forecast period.
  • The targeted therapy segment dominated the market in 2024 with a share of 50.66% in 2024. The immunotherapy segment is expected to grow at a significant CAGR over the forecast period.
  • The hospital pharmacy segment dominated the market with a share of 66.89% in 2024. The drug store and retail pharmacy segment is anticipated to witness a significant CAGR over the forecast period, owing to the increased availability of regulatory-approved drugs for consumption by patients seeking to cure NSCLC.
  • North America Non-small Cell Lung Cancer (NSCLC) therapeutics industry dominated globally with a market share of 35.41% in 2024. The Non-small Cell Lung Cancer (NSCLC) therapeutics industry in Asia Pacific is witnessing rapid growth fueled by rising lung cancer incidence, government investment in oncology care, and growing regional partnerships to expand access to biologics and targeted drugs.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Non-small cell lung cancer therapeutics market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Non-small Cell Lung Cancer Therapeutics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape
  • 3.5. Pipeline Analysis
  • 3.6. Pricing Analysis

Chapter 4. Non-small Cell Lung Cancer Therapeutics Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Non-small Cell Lung Cancer Therapeutics Market: Type Movement Analysis, USD Million, 2024 & 2030
  • 4.3. Squamous Cell Carcinoma
    • 4.3.1. Squamous Cell Carcinoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Large Cell Carcinoma
  • 4.5. Large Cell Carcinoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Adenocarcinoma
    • 4.6.1. Adenocarcinoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Non-small Cell Lung Cancer Therapeutics Market: Treatment Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Non-small Cell Lung Cancer Therapeutics Market: Treatment Movement Analysis, USD Million, 2024 & 2030
  • 5.3. Chemotherapy
    • 5.3.1. Chemotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Targeted Therapy
    • 5.4.1. Targeted Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Immunotherapy
    • 5.5.1. Immunotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Non-small Cell Lung Cancer Therapeutics Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Non-small Cell Lung Cancer Therapeutics Market: Distribution Channel Movement Analysis, USD Million, 2024 & 2030
  • 6.3. Hospital Pharmacy
    • 6.3.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Drug Store and Retail Pharmacy
    • 6.4.1. Drug Store and Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Online Pharmacy
    • 6.5.1. Online Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Non-small Cell Lung Cancer Therapeutics Market: Regional Estimates & Trend Analysis

  • 7.1. Non-small Cell Lung Cancer Therapeutics Market Share, By Region, 2024 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. China Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. F. Hoffmann-La Roche Ltd
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Mylan N.V.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Teva Pharmaceutical Industries Ltd.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Sanofi
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Pfizer Inc.
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. GSK plc
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Novartis AG
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Bayer AG
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Eli Lilly and Company
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Merck & Co., Inc
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of abbreviations
  • Table 3. North America Non-small Cell Lung Cancer Therapeutics Market, by region, 2018 - 2030 (USD Million)
  • Table 4. North America Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 5. North America Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 6. North America Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 7. US Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 8. US Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 9. US Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 10. Canada Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 11. Canada Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 12. Canada Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 13. Mexico Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 14. Mexico Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 15. Mexico Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 16. Europe Non-small Cell Lung Cancer Therapeutics Market, by region, 2018 - 2030 (USD Million)
  • Table 17. Europe Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 18. Europe Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 19. Europe Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20. Germany Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 21. Germany Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 22. Germany Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 23. UK Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 24. UK Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 25. UK Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26. France Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 27. France Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 28. France Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 29. Italy Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 30. Italy Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 31. Italy Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32. Spain Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 33. Spain Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 34. Spain Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 35. Denmark Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 36. Denmark Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 37. Denmark Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 38. Sweden Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 39. Sweden Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 40. Sweden Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 41. Norway Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 42. Norway Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 43. Norway Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 44. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market, by region, 2018 - 2030 (USD Million)
  • Table 45. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 46. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 48. China Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 49. China Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 50. China Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 51. Japan Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 52. Japan Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 53. Japan Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54. India Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 55. India Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 56. India Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 57. South Korea Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 58. South Korea Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 59. South Korea Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 60. Australia Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 61. Australia Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 62. Australia Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 63. Thailand Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 64. Thailand Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 65. Thailand Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 66. Latin America Non-small Cell Lung Cancer Therapeutics Market, by region, 2018 - 2030 (USD Million)
  • Table 67. Latin America Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 68. Latin America Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 69. Latin America Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 70. Brazil Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 71. Brazil Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 72. Brazil Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 73. Argentina Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 74. Argentina Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 75. Argentina Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 76. MEA Non-small Cell Lung Cancer Therapeutics Market, by region, 2018 - 2030 (USD Million)
  • Table 77. MEA Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 78. MEA Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 79. MEA Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 80. South Africa Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 81. South Africa Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 82. South Africa Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 83. Saudi Arabia Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 84. Saudi Arabia Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 85. Saudi Arabia Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 86. UAE Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 87. UAE Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 88. UAE Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 89. Kuwait Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 90. Kuwait Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 91. Kuwait Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Market research process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Non-small Cell Lung Cancer Therapeutics, Market Segmentation
  • Fig. 9 Market Snapshot, 2024
  • Fig. 10 Market Trends & Outlook
  • Fig. 11 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Non-small Cell Lung Cancer Therapeutics Market: Type Movement Analysis
  • Fig. 16 Global Non-small Cell Lung Cancer Therapeutics Market: Treatment Movement Analysis
  • Fig. 17 Global Non-small Cell Lung Cancer Therapeutics Market, for Distribution Channel, 2018 - 2030 (USD Million)
  • Fig. 18 Regional Marketplace: Key Takeaways
  • Fig. 19 Regional Outlook, 2024 & 2030
  • Fig. 20 Global Non-small Cell Lung Cancer Therapeutics Market: Region Movement Analysis
  • Fig. 21 North America Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 23 Canada Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 24 Mexico Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 25 Europe Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 26 Germany Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 27 UK Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 28 France Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 29 Italy Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 30 Spain Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 31 Denmark Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 32 Sweden Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 33 Norway Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 34 Asia Pacific Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 35 Japan Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 36 China Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 37 India Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 38 Australia Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 39 Thailand Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 40 South Korea Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 41 Latin America Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 42 Brazil Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 43 Argentina Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 44 Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 45 South Africa Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 46 Saudi Arabia Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 47 UAE Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 48 Kuwait Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)